SEATTLE--(BUSINESS WIRE)--May 11, 2006--Targeted Genetics Corporation (Nasdaq:TGEN - News) today announced that it has effected a one-for-ten reverse split of its common stock. The reverse stock split was approved by Targeted Genetics’ shareholders at the Annual Meeting of Shareholders on May 8, 2006. Upon today’s market open, Targeted Genetics’ common stock will begin trading on a split-adjusted basis under the trading symbol “TGEND” for a period of 20 trading days. Commencing June 12, 2006, Targeted Genetics’ common stock will resume trading under the symbol “TGEN.”
